Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic inflammatory response and nutritional biomarkers as predictors of nivolumab efficacy for gastric cancer
Tsutomu Namikawa, Keiichiro Yokota, Nobuhisa Tanioka, et al.
Surgery Today (2020) Vol. 50, Iss. 11, pp. 1486-1495
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors
Lilong Zhang, Wangbin Ma, Zhendong Qiu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 45
Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
Shufa Tan, Qin Zheng, Wei Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Pretreatment neutrophil-to-lymphocyte ratio is associated with immunotherapy efficacy in patients with advanced cancer: a systematic review and meta-analysis
Jialin Su, Li Yu-ning, Shuhua Tan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs
Chengyang Yu, Hao Jiang, Liezhi Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
Focus on the Dynamics of Neutrophil-to-Lymphocyte Ratio in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-Analysis and Systematic Review
Yusheng Guo, Dongqiao Xiang, Jiayu Wan, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5297-5297
Open Access | Times Cited: 33
Prognostic Nutritional Index Predicts Response and Prognosis in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Liwei Ni, Jing Huang, Jiyuan Ding, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 27
Clinical Impact of Nutrition and Inflammation Assessment Tools in Gastric Cancer Treatment
Toru Aoyama, Kentaro Hara, Keisuke Kazama, et al.
Anticancer Research (2022) Vol. 42, Iss. 11, pp. 5167-5180
Open Access | Times Cited: 26
A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer
Yongchao Zhang, Shanshan Chen, Hualei Chen, et al.
Cancer Medicine (2022) Vol. 12, Iss. 1, pp. 38-48
Open Access | Times Cited: 23
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis
Silvio Matsas, Pedro Nazareth Aguiar, Auro del Giglio
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 1, pp. 33-51
Open Access | Times Cited: 6
Prognostic nutritional index predicts the prognosis of patients with advanced esophageal cancer treated with immune checkpoint inhibitors: a retrospective cohort study
Mengjing Wu, Yunyun Zhu, Xiancheng Chen, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 1, pp. 54-63
Open Access | Times Cited: 11
Mechanisms and biomarkers of immune-related adverse events in gastric cancer
Pingan Ding, Pengpeng Liu, Lingjiao Meng, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 11
Prognostic value of neutrophil to lymphocyte ratio in gastric cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Siheng Zhang, Chao Qiu, Hanzhi Yu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Baseline (modified) Glasgow prognostic score as a predictor of therapeutic response to immune checkpoint inhibitors in solid tumors: A systematic review and meta‑analysis
Hong Ye, Meifang Li
Oncology Letters (2025) Vol. 29, Iss. 4
Open Access
Predictive biomarkers for immunotherapy in gastric cancer
Sijia Li, Huayuan Liang, Guoxin Li
Journal of Cancer Metastasis and Treatment (2025)
Open Access
Significance of Naples prognostic score for postoperative complications after colorectal cancer surgery
Masahisa Ohkuma, Yasuhiro Takano, Keisuke Goto, et al.
Surgery Today (2025)
Closed Access
Predictive Impact of Prognostic Nutritional Index on Pembrolizumab for Metastatic Urothelial Carcinoma Resistant to Platinum-based Chemotherapy
Yudai Ishiyama, Tsunenori Kondo, Yuki Nemoto, et al.
Anticancer Research (2021) Vol. 41, Iss. 3, pp. 1607-1614
Open Access | Times Cited: 23
The new prognostic score for unresectable or recurrent gastric cancer treated with nivolumab: A multi‐institutional cohort study
Sho Sato, Yoko Oshima, Yu Matsumoto, et al.
Annals of Gastroenterological Surgery (2021) Vol. 5, Iss. 6, pp. 794-803
Open Access | Times Cited: 23
A Composite Biomarker of Derived Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio Correlates With Outcomes in Advanced Gastric Cancer Patients Treated With Anti-PD-1 Antibodies
Yuting Pan, Haiyan Si, Guochao Deng, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 15
Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
Tibera K. Rugambwa, Omar Ahmed, Xiangyang Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Effect of Prognostic Nutrition Index in Gastric or Gastro-oesophageal Junction Cancer Patients Undergoing Nivolumab Monotherapy
Hayato Watanabe, Takanobu Yamada, KEISUKE KOMORI, et al.
In Vivo (2021) Vol. 35, Iss. 1, pp. 563-569
Open Access | Times Cited: 17
Prognostic relevance of prognostic nutritional indices in gastric or gastro-esophageal junction cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Shufu Hou, Dandan Song, Ruiqi Hao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
The prognostic value of prognostic nutritional index in advanced cancer receiving PD‐1/L1 inhibitors: A meta‐analysis
Pengfei Li, Yutian Lai, Long Tian, et al.
Cancer Medicine (2022) Vol. 11, Iss. 16, pp. 3048-3056
Open Access | Times Cited: 11
Research Progress of Biomarkers for Immune Checkpoint Inhibitors on Digestive System Cancers
Jingting Wang, Xiao Ma, Zhongjun Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Prognostic value of neutrophil‐to‐lymphocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: A meta‐analysis
Lili Li, L. Pan
The Kaohsiung Journal of Medical Sciences (2023) Vol. 39, Iss. 8, pp. 842-852
Open Access | Times Cited: 6
Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later‐line nivolumab monotherapy—The Asahikawa Gastric Cancer Cohort Study (AGCC)
Kazuyuki Tanaka, Hiroki Tanabe, Hiroki Sato, et al.
Cancer Medicine (2021) Vol. 11, Iss. 2, pp. 406-416
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top